INBX
Inhibrx Biosciences, Inc.Healthcare$63.53
▲ Bullish
Mkt Cap: $928.0M|Float: 7.8M|SI: 23.9%|DTC: 11.2
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
76.7%
52W Range
$11-$95
ATR(14)
$4.83
Exp. Move
±8.4%
P/C Ratio
0.08
Earnings
May 13
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
INBX Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $0.2M
- Max Pain
- $65.00
- Expected Move
- ±8.4%
- Put/Call OI
- 0.08
- Net Premium
- $0.0M
- Spot Price
- $63.53
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$5.35 | ±8.4% | $58.18 | $68.88 |
| 2026-05-15 | 43 | ±$19.65 | ±30.9% | $43.88 | $83.18 |
| 2026-08-21 | 141 | ±$16.35 | ±25.7% | $47.18 | $79.88 |
| 2027-01-15 | 288 | ±$18.00 | ±28.3% | $45.53 | $81.53 |
Explore INBX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.